Anika Therapeutics (ANIK) Other Gross PP&E Adjustments: 2010-2025
Historic Other Gross PP&E Adjustments for Anika Therapeutics (ANIK) over the last 13 years, with Sep 2025 value amounting to -$26.0 million.
- Anika Therapeutics' Other Gross PP&E Adjustments rose 15.18% to -$26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $155.7 million, marking a year-over-year increase of 458.36%. This contributed to the annual value of $57.1 million for FY2024, which is 14.08% up from last year.
- According to the latest figures from Q3 2025, Anika Therapeutics' Other Gross PP&E Adjustments is -$26.0 million, which was down 139.95% from $65.1 million recorded in Q2 2025.
- In the past 5 years, Anika Therapeutics' Other Gross PP&E Adjustments registered a high of $65.1 million during Q2 2025, and its lowest value of -$34.8 million during Q2 2022.
- Its 3-year average for Other Gross PP&E Adjustments is $1.2 million, with a median of -$30.7 million in 2024.
- As far as peak fluctuations go, Anika Therapeutics' Other Gross PP&E Adjustments plummeted by 59.13% in 2022, and later skyrocketed by 308.31% in 2025.
- Anika Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at $62.6 million in 2021, then fell by 3.22% to $60.6 million in 2022, then decreased by 17.42% to $50.1 million in 2023, then climbed by 14.08% to $57.1 million in 2024, then grew by 15.18% to -$26.0 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$26.0 million for Q3 2025, versus $65.1 million for Q2 2025 and $59.5 million for Q1 2025.